| Dr Reddys Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500124 |
NSE Symbol : DRREDDY |
P/E(TTM) : 147.31 |
|
ISIN Demat : INE089A01031 |
Div & Yield% : 0.68 |
EPS(TTM) : 7.95 |
|
Book Value(₹) : 377.95 |
Market Cap(₹Cr) : 97,749.41 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 5,115.00 | 3,802.60 | 4,266.40 | 4,602.90 | 7,788.70 | 5,546.30 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 5,115.00 | 3,802.60 | 4,266.40 | 4,602.90 | 7,788.70 | 5,546.30 |
| Other Operating Income | 21.60 | 19.40 | 16.30 | 15.70 | 20.80 | 16.60 |
| Other Income | 440.40 | 567.20 | 360.30 | 364.20 | 398.30 | 414.40 |
| Total Income | 5,577.00 | 4,389.20 | 4,643.00 | 4,982.80 | 8,207.80 | 5,977.30 |
| Total Expenditure | 4,689.20 | 4,321.90 | 4,183.10 | 4,138.30 | 3,972.50 | 4,119.90 |
| PBIDT | 887.80 | 67.30 | 459.90 | 844.50 | 4,235.30 | 1,857.40 |
| Interest | 73.10 | 54.30 | 41.40 | 33.40 | 19.20 | 31.10 |
| PBDT | 814.70 | 13.00 | 418.50 | 811.10 | 4,216.10 | 1,826.30 |
| Depreciation | 317.70 | 318.50 | 314.30 | 294.80 | 279.80 | 264.50 |
| Tax | 50.10 | -114.70 | 13.00 | 77.70 | 941.70 | 364.30 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 42.20 | 28.60 | 0.60 | 51.30 | 33.40 | -3.20 |
| Reported Profit After Tax | 404.70 | -219.40 | 90.60 | 387.30 | 2,961.20 | 1,200.70 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 404.70 | -219.40 | 90.60 | 387.30 | 2,961.20 | 1,200.70 |
| EPS (Unit Curr.) | 4.86 | -2.63 | 1.09 | 4.65 | 35.59 | 14.41 |
| EPS (Adj) (Unit Curr.) | 4.86 | -2.63 | 1.09 | 4.65 | 35.59 | 14.41 |
| Calculated EPS (Unit Curr.) | 4.85 | -2.63 | 1.09 | 4.64 | 35.46 | 14.40 |
| Calculated EPS (Adj) (Unit Curr.) | 4.85 | -2.63 | 1.09 | 4.64 | 35.46 | 14.40 |
| Calculated EPS (Ann.) (Unit Curr.) | 19.39 | -10.51 | 4.34 | 18.55 | 141.85 | 57.59 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 19.39 | -10.51 | 4.34 | 18.55 | 141.85 | 57.59 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 83.50 | 83.50 | 83.50 | 83.50 | 83.50 | 83.40 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.36 | 1.77 | 10.78 | 18.35 | 54.38 | 33.49 |
| PBDTM(%) | 15.93 | 0.34 | 9.81 | 17.62 | 54.13 | 32.93 |
| PATM(%) | 7.91 | -5.77 | 2.12 | 8.41 | 38.02 | 21.65 |
